The NIH said results of two studies of blood serum from people who had received Covaxin suggest that the vaccine generates antibodies that effectively neutralise the B.1.1.7 (Alpha) and B.1.617 (Delta) variants of SARS-CoV-2, first identified in the United Kingdom and India, respectively.
In September, Bharat Biotech aimed to supply 35 million doses, and take this up to 55 million by October. This is still less than what the Indian government expects from the company.
As states grapple with a shortage of coronavirus vaccines, the Centre on Thursday said that over two billion doses will be made available in the country in five months between August and December, enough to vaccinate the entire population.
The health ID will contain information about medical data, prescriptions and diagnostic reports and summaries of previous discharge from hospitals for ailments. The mission is expected to bring efficiency and transparency in healthcare services in the country.
Each vaccination session will cater to a maximum of 100 beneficiaries and the Union Health Ministry has advised states not to organise 'unreasonable numbers of vaccination per site per day'.
The NTAGI has also stated that those having laboratory test proven SARS-CoV-2 illness should defer COVID-19 vaccination for six months after recovery, the sources said.
'Almost 70 per cent production time of a vaccine is dedicated to quality control, which is done through several hundred tests.'
As India gets ready to roll out one of the largest vaccine programmes, billionaire Mukesh Ambani on Tuesday said his group is working with authorities to provide technology tools and backbone for mass inoculation against COVID-19. Ambani's telecom venture Jio was rolled out four years back, offering free voice calling and dirt-cheap data. Today, Jio is India's largest telecom operator with over 400 million users, each connected to the internet. At a Facebook event, Ambani said the government's digital push kept the country running even during the pandemic and is now helping in the rollout of one of the largest vaccination programmes.
The Medicines and Healthcare Regulatory Agency, which had been formally tasked by the UK government last month with the process of clearance after the jab emerged "safe and effective" against the novel coronavirus in human trials, is expected to authorise the vaccine by December 28 or 29 after the final data is provided on Monday, 'The Daily Telegraph' quoted senior government sources as indicating.
Laws governing compensation in case of adverse side effects for Covaxin and Covishield may differ in accordance with the kind of approvals given, say legal experts.
Flipkart's co-founders Sachin and Binni Bansal made their debut at 86th position with a net worth of $1.3 billion each.
The British-Swedish pharmaceutical major and the UK's medicines regulator said that the vaccines produced by Oxford University in collaboration with AstraZeneca to protect against COVID-19 are safe.
Replying to a short duration discussion on COVID-19 management in Rajya Sabha, the minister said technology transfer to several companies has started and they will begin production in the coming days to reduce vaccine shortage in the country.
UP Rs 50 billion, followed by Maharashtra, Bihar, and West Bengal which may need close to Rs 25 billion for the massive task.
The ministry further stated that it was advisable to receive a complete schedule of the anti-coronavirus vaccine irrespective of past history of infection with COVID-19 as this will help in developing a strong immune response against the disease.
Young Indian entrepreneurs hope to share some of the limelight too at the Hyderabad event.
The government is considering setting up air freight stations to enable direct movement of vaccines from pharmaceutical factories to the aircraft.
Based on this price, state governments, private hospitals, industrial establishments, etc would be able to procure vaccine doses from the manufacturers.
Addressing a press conference, NITI Aayog Member (Health) Dr V K Paul said the question of the third wave keeps coming up because the population is still 'very vulnerable' to the infection.
By 2022, there is a plan to make an mRNA-technology vaccine, for which it has tied up with Canadian firm Providence Therapeutics.
Experts said attempts from China have increased in the last year, which further amplified after the Indian government banned Chinese applications post the Galwan clash.
A steady decline in new COVID-19 cases has been recorded in India for the last 20 days, with 24 states witnessing a dip in active cases since the last week, the Union health ministry said.
In view of the unprecedented and peculiar circumstances under which vaccination drive is devised as an executive policy, the "wisdom of the executive should be trusted", it said.
Behind each Covid vaccine are hundreds of parents, who had the courage and conviction to come forth with their children for the trial of a vaccine which was, until then, untried in that age group, reports Sindhu Bhattacharya.
Eminent virologist Shahid Jameel COVID-19 cases in the second wave also won't come down in as steady a fashion as they did after the first wave.
'The prioritisation of groups for COVID-19 vaccine shall be based on two key considerations -- occupational hazard and risk of exposure to infection, and the risk of developing severe disease and increased mortality'
Shringla visited Dhaka in March last after assuming office of the Indian Foreign Secretary in January this year.
The first nationwide mock drill was held on January 2 which, the health ministry said, helped to iron out any glitches in the final execution and further refinement of the operational procedures.
'It is a balanced and prudent Budget that sets the foundation for future growth in the economy.'
The international team of researchers combined lab-based experiments and epidemiology of vaccine breakthrough infections, showing that the Delta variant is better at replicating and spreading than other commonly-observed variants.
'Ideally, the efficacy data of all the trials should be there in the public domain, and as soon as possible.' 'It is difficult to understand the reason behind the authorisation.'
He responded to criticism in certain circles following emergency use authorisation to the vaccine and said,"Indian companies do not deserve this backlash".
Prime Minister Narendra Modi will flag off the first phase of the pan India roll-out of COVID-19 vaccination drive at 10.30 am via video conferencing.
The benefits of modern medicine have led people to demand more from the State, and to value every life. Even a modest death toll caused by an epidemic today is unacceptable, says Dipankar Gupta.
Easing restrictions, all private hospitals were on Tuesday allowed to give the vaccines if they adhere to the laid down norms, while the 9 am to 5 pm timing was also done away with.
Jeff Bezos of Amazon tops the list for the second consecutive year with networth of $147 billion.
The Bengal outcome can have a marginal impact on national politics. Whereas elections in UP next year might still change the course ahead of the parliamentary poll in 2024, observes Virendra Kapoor.
A majority of India's billionaires gained wealth in the last one year in spite of the stock market decline.
Maharashtra and Punjab, which are recording a surge in new COVID-19 cases, tightened curbs on Friday and the chief minister of the western state said lockdown is an option, as India added close to 40,000 cases in the biggest daily increase in nearly four months.
'When there is so much anxiety, the Government of India should assure people on the vaccine issue and help the states demanding more supply that they will be provided the required quantities.' 'Any Centre-state conflict at this point of time is counter-productive and enhances people's anxieties that should be avoided.'
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances